1. A direct comparison of long‐ and short‐acting GLP‐1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment. Issue 2 (22nd August 2013) Authors: Gastaldelli, A.; Balas, B.; Ratner, R.; Rosenstock, J.; Charbonnel, B.; Bolli, G. B.; Boldrin, M.; Balena, R. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease. (10th February 2016) Authors: Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Møller, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Grønbæk, H.; Gastaldelli, A.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aleglitazar, a dual peroxisome proliferator‐activated receptor‐α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double‐blind trial. Issue 7 (1st February 2016) Authors: Stirban, A. O.; Andjelkovic, M.; Heise, T.; Nosek, L.; Fischer, A.; Gastaldelli, A.; Herz, M. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 7(2016) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease. (10th February 2016) Authors: Rosso, C.; Gaggini, M.; Saponaro, C.; Marietti, M.; Caviglia, G.P.; Carli, F.; Buzzigoli, E.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Gastaldelli, A.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity. Issue 9 (19th June 2019) Authors: Ahlin, S.; Cefalù, C.; Bondia‐Pons, I.; Capristo, E.; Marini, L.; Gastaldelli, A.; Mingrone, G.; Nolan, J. J. Journal: British journal of surgery Issue: Volume 106:Issue 9(2019) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity. Issue 9 (19th June 2019) Authors: Ahlin, S.; Cefalo, C.; Bondia‐Pons, I.; Capristo, E.; Marini, L.; Gastaldelli, A.; Mingrone, G.; Nolan, J. J. Journal: British journal of surgery Issue: Volume 106:Issue 9(2019) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bile acid composition modulates insulin resistance in non-diabetic patients with NAFLD. Issue 1 (February 2018) Authors: Rosso, C.; Younes, R.; Eslam, M.; Chen, F.W.; Cucco, M.; Gaggini, M.; Coulter, S.; Carli, F.; Barbieri, C.; Latta, V. della; Abate, M.L.; Saracco, G.M.; Gastaldelli, A.; George, J.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients. (March 2023) Authors: Lori, G.; Raggi, C.; Piombanti, B.; Pastore, M.; Booijink, R.; Navari, N.; Rovida, E.; Gastaldelli, A.; Andersen, J.; Lewinska, M.; Marra, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Gut–liver axis derangement due to lack of inflammasome activity leads to visceral obesity and NASH development. (15th February 2015) Authors: Agostinelli, L.; Rychlicki, C.; Mingarelli, E.; Saponaro, C.; Gaggini, M.; Buzzigoli, E.; Pierantonelli, I.; Saccomanno, S.; Pinto, C.; Trozzi, L.; Benedetti, A.; De Minicis, S.; Marzioni, M.; Gastaldelli, A.; Svegliati-Baroni, G. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IDF2022-0843 Hypercaloric diets impair hepatic tight junctions and lipid composition before affecting gut tight junctions. (March 2023) Authors: Meneses, M.J.; Patrício, B.; Belew, G.D.; Carli, F.; Jones, J.G.; Gastaldelli, A.; Macedo, M.P. Journal: Diabetes research and clinical practice Issue: Volume 197(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗